The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cetuximab every second week in combination with daily encorafenib in patients with BRAF V600E mutated metastatic colorectal cancer: Interim analysis from NEW BEACON.
 
Martina Eriksen
Consulting or Advisory Role - Pierre Fabre
Travel, Accommodations, Expenses - MSD
 
Per Pfeiffer
Consulting or Advisory Role - Amgen; Astellas Oncology; AstraZeneca; Boehringer Pharma GmbH; Celgene; Egetis Therapeutics; Eisai; Isofol Medical; Lilly; Merck Serono; MSD; Nordic Drugs; Pfizer; Pierre Fabre; PledPharma; Roche; Sanofi Aventis GmbH; Scandion Oncology; SERVIER; Shire; Taiho Oncology; Takeda
 
Kristoffer Rohrberg
Honoraria - MSD; MSD
Consulting or Advisory Role - Abbvie; Genmab
Research Funding - Alligator Bioscience (Inst); AstraZeneca (Inst); Bayer (Inst); Bioinvent (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Loxo (Inst); Merus (Inst); MonTa Biosciences (Inst); MSD (Inst); Navire (Inst); Novartis (Inst); Orion Clinical (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Symphogen (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst)
 
Christina Yde
No Relationships to Disclose
 
Lone Nørgård Petersen
Employment - Novo Nordisk (I)
 
Laurids Poulsen
Travel, Accommodations, Expenses - MSD; Takeda
 
Camilla Qvortrup
Consulting or Advisory Role - Merck KGaA; Pierre Fabre
Research Funding - miratis (Inst); MSD Oncology (Inst); Pfizer (Inst); pierre fabre (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Merck KGaA (Inst); Pierre Fabre (Inst); Roche (Inst); SERVIER (Inst)